Plus Therapeutics Inc (NASDAQ:PSTV) shares, rose in value on Wednesday, April 16, with the stock price up by 3.18% to the previous day’s close as strong demand from buyers drove the stock to $0.67.
Actively observing the price movement in the last trading, the stock closed the session at $0.65, falling within a range of $0.612 and $0.6935. The value of beta (5-year monthly) was 0.673. Referring to stock’s 52-week performance, its high was $2.67, and the low was $0.24. On the whole, PSTV has fluctuated by 20.35% over the past month.
With the market capitalization of Plus Therapeutics Inc currently standing at about $11.42 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-26.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.11M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PSTV’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PSTV currently trading nearly -31.71% and -32.77% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.01, while the 7-day volatility ratio is showing 16.53% which for the 30-day chart, stands at 32.07%. Furthermore, Plus Therapeutics Inc (PSTV)’s beta value is 0.94, and its average true range (ATR) is 0.21.
A comparison of Plus Therapeutics Inc (PSTV) with its peers suggests the former has fared considerably weaker in the market. PSTV showed an intraday change of 3.18% in last session, and over the past year, it shrunk by -61.40%%.
Data on historical trading for Plus Therapeutics Inc (NASDAQ:PSTV) indicates that the trading volumes over the past 10 days have averaged 2.8 and over the past 3 months, they’ve averaged 16.22 million. According to company’s latest data on outstanding shares, there are 17.00 million shares outstanding.
Nearly 2.55% of Plus Therapeutics Inc’s shares belong to company insiders and institutional investors own 11.11% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.25 million shares as on 2025-03-31, resulting in a short ratio of 0.03. According to the data, the short interest in Plus Therapeutics Inc (PSTV) stood at 741.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.14 million. The stock has fallen by -41.59% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PSTV stock heading into the next quarter.